Stay updated on Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Melanoma Immunotherapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added to the page; the government funding notice and the revision entry for v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a government funding notice at the top of the page. Updated Publications with a new author list for the CheckMate 067-related publication and a revision tag (v3.4.1); removed the previous publication entry (v3.4.0) containing an erratum.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a glossary toggle and updated metadata to show 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' with capitalization changes. Removed older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'.SummaryDifference0.1%

- Check42 days agoChange DetectedThe change is a minor update to the site's revision/version label, from Revision: v3.3.3 to Revision: v3.3.4, and does not modify the study details, eligibility criteria, results, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded the NEJM 2015 paper citation for Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (including the Erratum) and removed the earlier version of the citation.SummaryDifference0.0%

- Check63 days agoChange DetectedA consolidated 'Locations' section lists trial sites across multiple regions, replacing the previous scattered location headings. This affects how users identify and access eligible sites.SummaryDifference2%

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.